Transcranial magnetic stimulation can now be used for obsessive compulsive disorder, US FDA said in its Aug. 17 approval of the Brainsway Deep Transcranial Magnetic Stimulation System.
Jerusalem-based Brainsway Ltd
OCD Indication Approved For Brainsway TMS Device
US FDA used its de novo review pathway to approve Brainsway Ltd.’s Brainsway Deep Transcranial Magnetic Stimulation System to treat obsessive compulsive disorder.